[HTML][HTML] Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease

HJ Jansen, LJ Bohne, AM Gillis, RA Rose - Heart Rhythm O2, 2020 - Elsevier
Atrial fibrillation (AF) is prevalent in common conditions and acquired forms of heart disease,
including diabetes mellitus (DM), hypertension, cardiac hypertrophy, and heart failure. AF is …

Tailoring the Ablative Strategy for Atrial Fibrillation: A State‐of‐the‐Art Review

Z Palama, M Nesti, AG Robles, A Scara… - Cardiology …, 2022 - Wiley Online Library
In spite of technological progress and the improving skills of operators, atrial fibrillation (AF)
ablation results appear to date to be at a plateau. In any case, the superiority of ablation over …

[HTML][HTML] Time series RNA-seq analysis identifies MAPK10 as a critical gene in diabetes mellitus-induced atrial fibrillation in mice

F Liu, Y Deng, Y Zhao, Z Li, J Gao, Y Zhang… - Journal of Molecular and …, 2022 - Elsevier
Atrial fibrillation (AF) is a major complication of type 2 diabetes mellitus (T2DM) and plays
critical roles in the pathogenesis of atrial remodeling. However, the differentially expressed …

Clinical observation of SGLT2 inhibitor therapy for cardiac arrhythmia and related cardiovascular disease in diabetic patients with controlled hypertension

SJ Jhuo, TH Lin, YH Lin, WC Tsai, IH Liu… - Journal of Personalized …, 2022 - mdpi.com
Sodium-glucose transporter 2 (SGLT2) inhibitors are new glucose-lowering agents that have
been proven to be beneficial for patients with cardiovascular diseases, heart failure, and …

Atrial fibrillation risk in patients suffering from type I diabetes mellitus. A review of clinical and experimental evidence

DA Vrachatis, KA Papathanasiou, C Kossyvakis… - Diabetes Research and …, 2021 - Elsevier
Atrial fibrillation (AF) and diabetes mellitus (DM) are commonly encountered in clinical
practice. Although, the long term macrovascular and microvascular sequela of DM are well …

Pharmacological therapy in patients with arrhythmias

L Sciarra, S Romano, G Paparella… - Frontiers in …, 2024 - frontiersin.org
Cardiac arrhythmias represent one of the most worldwide health problems. The incidence
and prevalence of the different forms of arrhythmia can be significantly different in relation to …

Catheter ablation of paroxysmal atrial fibrillation using high‐density mapping‐guided substrate modification

W Zhou, L Wang, B Zhou, L Wu - Pacing and Clinical …, 2018 - Wiley Online Library
Background This study aimed to evaluate the effect of substrate modification in paroxysmal
atrial fibrillation (AF) patients prior to circumferential pulmonary vein isolation (CPVI) …

不同左心房内径患者心电图P 波特征指标与阵发性房颤发生的相关性.

孙羽, 王庆义, 祝娜 - Journal of Practical Electrocardiology, 2021 - search.ebscohost.com
目的探究不同左心房内径(left atrial diameter, LAD) 患者心电图P 波特征指标与阵发性房颤(
paroxysmal atrial fibrillation, PAF) 发生的相关性. 方法选取75 例PAF 患者(房颤组), 根据LAD …

Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

M Matta, A Saglietto, P De Salvo, A Bissolino… - Herz, 2019 - iris.unito.it
Atrial fibrillation (AF) is the most commonly sustained arrhythmia, and patients with diabetes
mellitus (DM) exhibit an increased incidence of AF. Besides DM, heart failure (HF) shares …

[HTML][HTML] The whole term efficacy of different treatments in paroxysmal atrial fibrillation in aging: a meta-analysis of randomized controlled trials

Y Sun, L Wang, X Yang - Aging (Albany NY), 2021 - ncbi.nlm.nih.gov
Antiarrhythmic drug therapy (ADT) and catheter ablation (CA) are the main treatments for
paroxysmal atrial fibrillation. However, the short-and long-term clinical efficacy of these …